Trends toward higher double positivity were noted, only achieving significance for PD-1+LAG3+ cells (46.57 ± 5.1%) in late relapsed multiple myeloma compared with HD CAR T cells (26.0 ± 4.2%, P < 0.05; Fig. 3D and E). This evidence concerns the gene LAG3 and AL amyloidosis.